A large new meta-analysis published in the Lancet provides the best evidence yet that the??cobalt-chromium everolimus eluting (CoCr-EES) stents????(Xience and Promus)??have a significantly lower rate of stent thrombosis than bare-metal stents BMS) and other drug-eluting stents (DES). Tullio Palmerini and colleagues analyzed data from 49 randomized trials comparing different stents in more than 50,000 patients. ...
FEEDS
